CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 79% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English

Trade Greenwich LifeSciences, Inc. - GLSI CFD

11.64
3.32%
  • Summary
  • Historical Data
  • Events
  • Income Statement
  • Balance Sheet
  • Cash Flow
  • Ownership
Trading Conditions
Spread 0.16
Long position overnight fee

Long position overnight fee


Margin. Your investment $1,000.00
Overnight fee -0.026207 %
Charges from full value of position ($-4.98)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.026207%
Short position overnight fee

Short position overnight fee


Margin. Your investment $1,000.00
Overnight fee 0.003985 %
Charges from full value of position ($0.76)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
0.003985%
Overnight fee time 22:00 (UTC)
Min traded quantity 1
Currency USD
Margin 5%
Stock exchange United States of America
Commission on trade 0%

*Information provided by Capital.com

Greenwich Lifesciences Inc ESG Risk Ratings

High Medium Low Negligible

‘D’ score indicates poor relative ESG performance and insufficient degree of transparency in reporting material ESG data publicly.

More ESG coverage

Key Stats
Prev. Close* 12.04
Open* 11.48
1-Year Change* -16.45%
Day's Range* 11.37 - 11.91
52 wk Range 7.58-21.50
Average Volume (10 days) 15.17K
Average Volume (3 months) 279.61K
Market Cap 136.19M
P/E Ratio -100.00K
Shares Outstanding 12.85M
Revenue N/A
EPS -0.70
Dividend (Yield %) N/A
Beta -100.00K
Next Earnings Date Mar 31, 2024

All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Dec 8, 2023 11.64 0.16 1.39% 11.48 11.91 11.37
Dec 7, 2023 12.04 0.25 2.12% 11.79 12.23 11.78
Dec 6, 2023 12.13 0.51 4.39% 11.62 12.37 11.44
Dec 5, 2023 11.79 0.50 4.43% 11.29 11.97 11.23
Dec 4, 2023 11.39 0.23 2.06% 11.16 11.42 11.16
Dec 1, 2023 11.66 0.23 2.01% 11.43 11.75 11.25
Nov 30, 2023 11.36 0.27 2.43% 11.09 11.68 10.87
Nov 29, 2023 11.19 0.21 1.91% 10.98 11.74 10.98
Nov 28, 2023 11.35 0.17 1.52% 11.18 11.57 11.09
Nov 27, 2023 11.48 -0.50 -4.17% 11.98 11.98 11.20
Nov 24, 2023 11.74 0.64 5.77% 11.10 12.02 11.10
Nov 22, 2023 11.13 0.57 5.40% 10.56 11.63 10.56
Nov 21, 2023 10.57 -0.36 -3.29% 10.93 11.08 10.54
Nov 20, 2023 10.84 0.27 2.55% 10.57 10.94 10.53
Nov 17, 2023 10.59 -0.19 -1.76% 10.78 10.87 10.33
Nov 16, 2023 10.53 -0.26 -2.41% 10.79 11.18 10.53
Nov 15, 2023 10.78 0.62 6.10% 10.16 10.90 10.13
Nov 14, 2023 10.30 0.17 1.68% 10.13 10.40 9.91
Nov 13, 2023 10.03 -0.02 -0.20% 10.05 10.11 9.76
Nov 10, 2023 10.06 0.28 2.86% 9.78 10.17 9.78

Greenwich LifeSciences, Inc. Events

Time (UTC) Country Event
Friday, December 15, 2023

Time (UTC)

14:00

Country

US

Event

Greenwich Lifesciences Inc Annual Shareholders Meeting
Greenwich Lifesciences Inc Annual Shareholders Meeting

Forecast

-

Previous

-
Sunday, March 31, 2024

Time (UTC)

20:00

Country

US

Event

Q4 2023 Greenwich Lifesciences Inc Earnings Release
Q4 2023 Greenwich Lifesciences Inc Earnings Release

Forecast

-

Previous

-
View all events
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Total revenue 0 0 0 0 0
Revenue 0 0 0 0 0
Total Operating Expense 8.04025 4.59794 1.86379 3.42531 1.68966
Selling/General/Admin. Expenses, Total 1.56459 1.03843 0.80619 0.81889 0.41964
Research & Development 6.47567 3.55952 1.05761 2.60642 1.27002
Operating Income -8.04025 -4.59794 -1.86379 -3.42531 -1.68966
Net Income Before Taxes -7.82524 -4.57058 -1.86296 -3.42531 -1.68966
Net Income After Taxes -7.82524 -4.57058 -1.86296 -3.42531 -1.68966
Net Income Before Extra. Items -7.82524 -4.57058 -1.86296 -3.42531 -1.68966
Net Income -7.82524 -4.57058 -1.86296 -3.42531 -1.68966
Income Available to Common Excl. Extra. Items -7.82524 -4.57058 -1.86296 -3.42531 -1.68966
Income Available to Common Incl. Extra. Items -7.82524 -4.57058 -1.86296 -3.42531 -1.68966
Diluted Net Income -7.82524 -4.57058 -1.86296 -3.42531 -1.68966
Diluted Weighted Average Shares 12.9138 12.9441 12.7035 11.9702 11.9702
Diluted EPS Excluding Extraordinary Items -0.60596 -0.3531 -0.14665 -0.28615 -0.14116
Dividends per Share - Common Stock Primary Issue 0 0
Diluted Normalized EPS -0.60596 -0.3531 -0.14665 -0.28615 -0.14116
Interest Income (Expense), Net Non-Operating 0.21502 0.02737 0.00083
Sep 2023 Jun 2023 Mar 2023 Dec 2022 Sep 2022
Total revenue 0 0 0 0 0
Revenue 0 0 0 0 0
Total Operating Expense 2.50293 1.74783 2.24108 2.89468 2.38306
Selling/General/Admin. Expenses, Total 0.34476 0.36826 0.41318 0.43658 0.65957
Research & Development 2.15817 1.37957 1.82791 2.4581 1.72349
Operating Income -2.50293 -1.74783 -2.24108 -2.89468 -2.38306
Interest Income (Expense), Net Non-Operating 0.11114 0.11945 0.11618 0.10417 0.06404
Net Income Before Taxes -2.39179 -1.62837 -2.1249 -2.79051 -2.31902
Net Income After Taxes -2.39179 -1.62837 -2.1249 -2.79051 -2.31902
Net Income Before Extra. Items -2.39179 -1.62837 -2.1249 -2.79051 -2.31902
Net Income -2.39179 -1.62837 -2.1249 -2.79051 -2.31902
Income Available to Common Excl. Extra. Items -2.39179 -1.62837 -2.1249 -2.79051 -2.31902
Income Available to Common Incl. Extra. Items -2.39179 -1.62837 -2.1249 -2.79051 -2.31902
Diluted Net Income -2.39179 -1.62837 -2.1249 -2.79051 -2.31902
Diluted Weighted Average Shares 12.8482 12.8482 12.8482 12.4525 12.8235
Diluted EPS Excluding Extraordinary Items -0.18616 -0.12674 -0.16539 -0.22409 -0.18084
Dividends per Share - Common Stock Primary Issue 0 0 0 0
Diluted Normalized EPS -0.18616 -0.12674 -0.16539 -0.22409 -0.18084
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Total Current Assets 13.468 27.2043 28.6604 0.00684 0.0851
Cash and Short Term Investments 13.468 27.2043 28.6604 0.00684 0.0851
Cash 13.468 27.2043 28.6604 0.00684 0.0851
Total Assets 13.477 27.2169 28.6766 0.02667 0.10855
Intangibles, Net 0.009 0.01262 0.01623 0.01984 0.02344
Total Current Liabilities 0.26291 0.38517 1.04549 1.37709 0.7286
Payable/Accrued 0.22085 0.22085 0.71097 0.73031 0.27756
Accrued Expenses 0.04206 0.16433 0.05937 0.01163 0.03089
Notes Payable/Short Term Debt 0 0 0.27515 0.63515 0
Current Port. of LT Debt/Capital Leases 0.42015
Total Liabilities 0.26291 0.38517 1.04549 1.37709 10.2286
Total Long Term Debt 0 0 0 0 9.5
Long Term Debt 0 9.5
Total Equity 13.2141 26.8317 27.6311 -1.35042 -10.1201
Preferred Stock - Non Redeemable, Net 0.00198 0.00198
Common Stock 0.01285 0.01315 0.0127 0.00846 0.0002
Additional Paid-In Capital 54.674 60.4661 56.6954 25.8531 13.6664
Retained Earnings (Accumulated Deficit) -41.4728 -33.6475 -29.077 -27.214 -23.7887
Total Liabilities & Shareholders’ Equity 13.477 27.2169 28.6766 0.02667 0.10855
Total Common Shares Outstanding 12.8482 13.1478 12.7035 11.9457 11.9457
Sep 2023 Jun 2023 Mar 2023 Dec 2022 Sep 2022
Total Current Assets 9.14362 10.9442 11.9112 13.468 15.6381
Cash and Short Term Investments 9.14362 10.9442 11.9112 13.468 15.6381
Cash 9.14362 10.9442 11.9112 13.468 15.6381
Total Assets 9.14991 10.9514 11.9193 13.477 15.648
Intangibles, Net 0.00629 0.0072 0.0081 0.009 0.00991
Total Current Liabilities 0.29729 0.30155 0.23558 0.26291 0.23788
Payable/Accrued 0.2309 0.30046 0.22085 0.22085 0.22085
Accrued Expenses 0.06639 0.00108 0.01473 0.04206 0.01703
Notes Payable/Short Term Debt 0 0 0 0 0
Total Liabilities 0.29729 0.30155 0.23558 0.26291 0.23788
Total Long Term Debt 0 0 0 0 0
Total Equity 8.85263 10.6499 11.6837 13.2141 15.4101
Common Stock 0.01285 0.01285 0.01285 0.01285 0.01285
Additional Paid-In Capital 56.4576 55.8631 55.2686 54.674 54.0795
Retained Earnings (Accumulated Deficit) -47.6178 -45.226 -43.5977 -41.4728 -38.6823
Total Liabilities & Shareholders’ Equity 9.14991 10.9514 11.9193 13.477 15.648
Total Common Shares Outstanding 12.8482 12.8482 12.8482 12.8482 12.8482
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Net income/Starting Line -7.82524 -4.57058 -1.86296 -3.42531 -1.68966
Cash From Operating Activities -6.20003 -4.29155 -1.15296 -0.29327 -0.11495
Amortization 0.00361 0.00361 0.00361 0.00361 0.00361
Changes in Working Capital -0.12227 -0.38517 0.0284 2.93349 1.5711
Cash From Financing Activities -7.53622 2.83544 29.8065 0.215 0.2
Issuance (Retirement) of Stock, Net -7.53622 3.1106 30.1665 0 0.1
Issuance (Retirement) of Debt, Net 0 -0.27515 -0.36 0.215 0.1
Net Change in Cash -13.7362 -1.45611 28.6535 -0.07827 0.08505
Non-Cash Items 1.74387 0.66058 0.67799 0.19494 0
Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
Net income/Starting Line -2.1249 -7.82524 -5.03473 -2.7157 -1.96963
Cash From Operating Activities -1.55681 -6.20003 -4.02997 -2.48016 -1.94746
Amortization 0.0009 0.00361 0.00271 0.00181 0.0009
Non-Cash Items 0.59452 1.74387 1.14934 0.38977 0.16527
Changes in Working Capital -0.02733 -0.12227 -0.14729 -0.15604 -0.144
Cash From Financing Activities 0 -7.53622 -7.53622 -7.53622 -5.51371
Issuance (Retirement) of Stock, Net 0 -7.53622 -7.53622 -7.53622 -5.51371
Issuance (Retirement) of Debt, Net 0 0 0 0
Net Change in Cash -1.55681 -13.7362 -11.5662 -10.0164 -7.46117
Investor Name Investor Type Percent Outstanding Shares Held Shares change Holdings Date Turnover Rating
Patel (Snehal) Individual Investor 41.2641 5301677 6500 2023-10-25 LOW
McWilliams (David B) Individual Investor 4.8281 620327 0 2023-10-24 LOW
Hallock (Kenneth) Individual Investor 3.0925 397333 0 2023-10-24 LOW
Rothe (Eric) Individual Investor 2.4381 313255 0 2023-10-24 LOW
The Vanguard Group, Inc. Investment Advisor/Hedge Fund 2.1965 282215 -70109 2023-06-30 LOW
Thompson (Jaye L) Individual Investor 2.0224 259845 600 2023-09-26 LOW
Daugherty (Frank Joseph) Individual Investor 0.7015 90133 0 2023-10-24 LOW
Renaissance Technologies LLC Hedge Fund 0.6164 79200 28400 2023-06-30 HIGH
Columbia Threadneedle Investments (US) Investment Advisor/Hedge Fund 0.5308 68192 2584 2023-06-30 LOW
BlackRock Institutional Trust Company, N.A. Investment Advisor 0.4387 56368 620 2023-06-30 LOW
Geode Capital Management, L.L.C. Investment Advisor/Hedge Fund 0.3108 39933 0 2023-06-30 LOW
Millennium Management LLC Hedge Fund 0.2751 35348 -34456 2023-06-30 HIGH
GSA Capital Partners LLP Hedge Fund 0.26 33409 20751 2023-06-30 HIGH
State Street Global Advisors (US) Investment Advisor/Hedge Fund 0.1012 13002 0 2023-06-30 LOW
HRT Financial LP Investment Advisor 0.0789 10136 -8470 2023-06-30 HIGH
BofA Global Research (US) Research Firm 0.0394 5060 -703 2023-06-30 LOW
Charles Schwab Investment Management, Inc. Investment Advisor 0.0208 2671 0 2023-09-30 LOW
Newbridge Capital Management Investment Advisor/Hedge Fund 0.0117 1500 0 2023-09-30 LOW
Tower Research Capital LLC Hedge Fund 0.0096 1228 127 2023-06-30 HIGH
Lord, Abbett & Co. LLC Investment Advisor 0.0094 1207 0 2023-07-31 MED

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
Leverage
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Greenwich LifeSciences, Inc. Company profile

Greenwich LifeSciences, Inc., a clinical stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for breast cancer and other HER2/neu-expressing cancers. Its lead product candidate is the GP2, an immunotherapy, which has completed Phase IIb clinical trial to prevent recurrence of breast cancer following surgery. The company was formerly known as Norwell, Inc. and changed its name to Greenwich LifeSciences, Inc. in March 2018. Greenwich LifeSciences, Inc. was incorporated in 2006 and is headquartered in Stafford, Texas.
Industry: Biopharmaceuticals

3992 Bluebonnet Dr, Building 14
STAFFORD
TEXAS 77477
US

Income Statement

  • Annual
  • Quarterly

News

December RBA preview: no move expected at the final meeting of 2023

The RBA meets on Tuesday, 5th of December, 2023, at 2.30 PM (AEDT). We preview what to expect from this month’s decision.

14:47, 4 December 2023

CPI drops more than expected in Europe, Spain’s IBEX 35 looking to break pre-COVID highs

CPI drops more than expected in Europe, Spain’s IBEX 35 looking to break pre-COVID highs

12:39, 30 November 2023

Euro Zone CPI expected to continue dropping; economists warn about cutting too soon

EZ PI expected to drop further but speed of decline

08:16, 29 November 2023

A weaker Dollar drives gold higher

Gold prices have returned above $US2000 per ounce. We run through the factors driving gold and the commodity’s key technicals.

13:49, 28 November 2023

Q3 US Earnings Recap: Profits surprise to the upside, but outlook remains uncertain

US earnings for the third quarter were far better than expected. However, uncertainty about the outlook for company profits continues. We review the quarterly earnings and look ahead to what the markets expect from S&P 500 companies going forward.

13:20, 28 November 2023

RBNZ Preview: Rates expected to remain unchanged at final meeting of 2023

The RBNZ meets for the final time this year on Wednesday, 29th of November, 2023. We preview what to expect and how it could impact the New Zealand Dollar.

13:04, 28 November 2023

Crude prices slide on OPEC+ uncertainty

Crude prices have chopped sideways amid signs of turmoil within OPEC+. We look at the fundamentals of the oil market and the technical levels of WTI.

12:55, 28 November 2023

People also watch

BTC/USD

42,278.50 Price
-3.620% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 22:00 (UTC)
Spread 106.00

US100

16,050.30 Price
-0.140% 1D Chg, %
Long position overnight fee -0.0262%
Short position overnight fee 0.0040%
Overnight fee time 22:00 (UTC)
Spread 1.8

XRP/USD

0.63 Price
-6.240% 1D Chg, %
Long position overnight fee -0.0753%
Short position overnight fee 0.0069%
Overnight fee time 22:00 (UTC)
Spread 0.01168

Gold

1,996.35 Price
-0.420% 1D Chg, %
Long position overnight fee -0.0199%
Short position overnight fee 0.0117%
Overnight fee time 22:00 (UTC)
Spread 0.50

Still looking for a broker you can trust?

Join the 570.000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading